美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NewLink Genetics Corp.

0.8900

+0.0000

成交量：- -

成交額：- -

市值：3,319.70萬

市盈率：-0.77

高：0.8900

開：0.8900

低：0.8900

收：0.8900

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

NewLink Genetics Corp.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.newlinkgenetics.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Newlink Genetics Corporation是一家生物製藥公司，專註於發現、開發和商業化免疫治療產品，改善癌症患者的治療方案。公司的產品包括生物和小分子免疫治療候產品。公司的生物產品是基於公司的專有超急性免疫治療技術，其目的是刺激人體免疫系統。公司的小分子產品的重點是通過抑制吲哚胺-(2、3)-加雙氧酶途徑打破癌症免疫系統的容忍度。公司相信公司免疫治療技術有可能產生多個產品針對廣泛的腫瘤癥狀治療，其可以單獨或結合其他療法進行治療。該公司於1999年6月4日以NewLink Genetics Corporation為名在特拉華州成立。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NLNK/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NLNK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","market":"US","secType":"STK","nameCN":"NewLink Genetics Corp.","latestPrice":0.89,"timestamp":1584561600000,"preClose":0.89,"halted":8,"volume":0,"delay":0,"floatShares":22854328,"shares":37300000,"eps":-1.15,"marketStatus":"盤後交易","change":0,"latestTime":"05-06 18:11:41 EDT","open":0.89,"high":0.89,"low":0.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.15,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1746576000000},"marketStatusCode":4,"symbolChange":{"newSymbol":"LUMO","executeDate":"2020-03-19"},"adr":0,"adrRate":0,"listingDate":1320987600000,"exchange":"NASDAQ","adjPreClose":0.89,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","floatShares":22854328,"roa":"-21.70%","roe":"-44.31%","lyrEps":-1.152689,"shares":37300000,"dividePrice":0,"high":0.89,"amplitude":0,"preClose":0.89,"low":0.89,"week52Low":0.8403,"pbRate":"0.42","week52High":3.6,"institutionHeld":0,"latestPrice":0.89,"eps":-1.15,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.15,"open":0.89},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.newlinkgenetics.com","stockEarnings":[{"period":"1week","weight":-0.8889},{"period":"1month","weight":-0.8889},{"period":"3month","weight":-0.8889},{"period":"6month","weight":-0.8889},{"period":"1year","weight":-0.8889},{"period":"ytd","weight":-0.8889}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Newlink Genetics Corporation是一家生物製藥公司，專註於發現、開發和商業化免疫治療產品，改善癌症患者的治療方案。公司的產品包括生物和小分子免疫治療候產品。公司的生物產品是基於公司的專有超急性免疫治療技術，其目的是刺激人體免疫系統。公司的小分子產品的重點是通過抑制吲哚胺-(2、3)-加雙氧酶途徑打破癌症免疫系統的容忍度。公司相信公司免疫治療技術有可能產生多個產品針對廣泛的腫瘤癥狀治療，其可以單獨或結合其他療法進行治療。該公司於1999年6月4日以NewLink Genetics Corporation為名在特拉華州成立。","exchange":"NASDAQ","name":"NewLink Genetics Corp.","nameEN":"NewLink Genetics Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLNK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-19","symbol":"NLNK","oldSymbol":"NLNK","newSymbol":"LUMO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584590400000},{"market":"US","date":"2020-03-19","symbol":"NLNK","type":"split","dateTimestamp":1584590400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2020-02-28","symbol":"NLNK","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1582866000000,"reportTimeType":"pre","actualEps":-1.98},{"date":"2019-11-06","symbol":"NLNK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.27,"defaultRemindTime":1573030800000,"name":null,"time":"盤前","dateTimestamp":1573016400000,"actualEps":null},{"market":"US","date":"2019-05-08","symbol":"NLNK","fiscalQuarterEnding":"2019/03","expectedEps":-0.31,"name":null,"time":"盤後","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLNK\",market:\"US\",delay:false,,,undefined,":{}}}